| 2201 |
Agonism, Retinoic acid receptor
Short Name
RAR agonism
|
0 |
Molecular |
Jan 14, 2024 |
Jan 24, 2024 |
3 AOPs
|
| 2202 |
Altered expression of cell cycle genes
Short Name
Altered expression of cell cycle genes
|
0 |
Molecular |
Jan 14, 2024 |
Mar 7, 2024 |
3 AOPs
|
| 2203 |
Decreased proliferation of cortical neural progenitor cells
Short Name
Decreased proliferation of cortical NPCs
|
0 |
Cellular |
Jan 14, 2024 |
Jan 29, 2024 |
3 AOPs
|
| 2204 |
Altered brain morphology
Short Name
Altered brain morphology
|
0 |
Organ |
Jan 14, 2024 |
Jan 14, 2024 |
520: Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory
|
| 2205 |
Increased, essential element imbalance
Short Name
Increased, essential element imbalance
|
0 |
Molecular |
Jan 24, 2024 |
May 9, 2024 |
521: Essential element imbalance leads to reproductive failure via oxidative stress
|
| 2206 |
Increased, histomorphological alteration of testis
Short Name
Increased, histomorphological alteration of testis
|
1 |
Tissue |
Jan 24, 2024 |
Apr 10, 2024 |
521: Essential element imbalance leads to reproductive failure via oxidative stress
|
| 2207 |
inhibition, EKR1/2 signaling pathway
Short Name
inhibition, EKR1/2 signaling pathway
|
0 |
Cellular |
Jan 25, 2024 |
Jan 25, 2024 |
522: Estrogen antagonism leading to increased risk of autism-like behavior
|
| 2208 |
Aberrant, synaptic formation and plasticity
Short Name
Aberrant, synaptic formation and plasticity
|
0 |
Organ |
Jan 25, 2024 |
Jan 25, 2024 |
2 AOPs
|
| 2209 |
autism-like behavior
Short Name
autism-like behavior
|
0 |
Individual |
Jan 25, 2024 |
Jan 25, 2024 |
522: Estrogen antagonism leading to increased risk of autism-like behavior
|
| 2210 |
Reduced cortical thickness
Short Name
Reduced cortical thickness
|
0 |
Tissue |
Feb 2, 2024 |
Feb 2, 2024 |
523: Retinoic acid receptor agonism during neurodevelopment leading to microcephaly
|
| 2211 |
Microcephaly
Short Name
Microcephalus
|
0 |
Organ |
Feb 2, 2024 |
Feb 2, 2024 |
581: Glucocorticoid receptor (GR) activation during development leads to cognitive function (COG) decrease
|
| 2212 |
Epididymal agenesis
Short Name
Epididymal agenesis
|
1 |
Organ |
Mar 19, 2024 |
Dec 3, 2024 |
526: Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis
|
| 2213 |
Impaired, urethral tube closure
Short Name
Impaired, urethral tube closure
|
1 |
Organ |
Mar 19, 2024 |
Dec 3, 2024 |
527: Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased
|
| 2214 |
Decreased, Insulin-like peptide 3 (INSL3)
Short Name
Decreased, INSL3
|
1 |
Molecular |
Mar 19, 2024 |
Dec 3, 2024 |
528: Decreased Insulin-like peptide 3 (INSL3) leads to Malformation, cryptorchidism - maldescended testis
|
| 2215 |
Decrease Left Ventricular function
Short Name
Decrease LV function
|
0 |
Organ |
Apr 3, 2024 |
Apr 3, 2024 |
2 AOPs
|
| 2216 |
Binding of antagonist to thyroid hormone receptor
Short Name
Binding of antagonist to thyroid hormone receptor
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2217 |
Binding of antagonist to glucocorticoid hormone receptor
Short Name
Binding of antagonist to glucocorticoid hormone receptor
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2218 |
Binding of (ant)agonist to liver X receptor
Short Name
Binding of (ant)agonist to liver X receptor
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2219 |
Binding of (ant)agonist to peroxisome proliferator–activated receptor alpha
Short Name
Binding of (ant)agonist to PPAR alpha
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2220 |
Antagonism, Glucocorticoid hormone receptor
Short Name
GR antagonism
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2221 |
Altered Liver X receptor activity
Short Name
LXR activity, altered
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2222 |
Altered peroxisome proliferator–activated receptor alpha activity
Short Name
PPAR alpha activity, altered
|
0 |
Molecular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2223 |
Reduced number of oligodendrocytes
Short Name
Reduced number of oligodendrocytes
|
0 |
Cellular |
Apr 12, 2024 |
Apr 12, 2024 |
525: Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory
|
| 2224 |
Dysregulation of transcriptional expression within PPAR signaling network
Short Name
Dysregulation of transcriptional expression within PPAR signaling network
|
1 |
Molecular |
May 8, 2024 |
May 23, 2024 |
529: Xenobiotic binding to peroxisome proliferator-activated receptors (PPARs) causes dysregulation of lipid metabolism leading to liver steatosis
|
| 2225 |
Disrupted Lipid Storage
Short Name
Disrupted Lipid Storage
|
1 |
Cellular |
May 8, 2024 |
May 23, 2024 |
529: Xenobiotic binding to peroxisome proliferator-activated receptors (PPARs) causes dysregulation of lipid metabolism leading to liver steatosis
|